Neurogranin as biomarker in CSF is non-specific to Alzheimer's disease dementia

Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers

(2021) Michelle M. Mielke et al.   Alzheimers & Dementia

Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study

(2021) Kaitlin Blackstone Casaletto et al.   NEUROLOGY

Biomarkers for neurodegenerative diseases

(2021) Oskar Hansson   NATURE MEDICINE

Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment

(2020) Weilin Liu et al.   Translational Psychiatry

Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's disease

(2019) Suzanne E. Schindler et al.   Alzheimers & Dementia

Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin

(2019) Michelle M. Mielke et al.   Alzheimers & Dementia

Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration

(2019) Kina Höglund et al.   NEUROBIOLOGY OF DISEASE

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology

(2018) Erik Portelius et al.   ACTA NEUROPATHOLOGICA

Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease

(2018) Courtney L. Sutphen et al.   Alzheimers & Dementia

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Added Diagnostic Value of Cerebrospinal Fluid Biomarkers for Differential Dementia Diagnosis in an Autopsy-Confirmed Cohort

(2018) Ellis Niemantsverdriet et al.   JOURNAL OF ALZHEIMERS DISEASE

Neurogranin as a predictor of memory and executive function decline in MCI patients

(2018) Alison Headley et al.   NEUROLOGY

CSF neurogranin or tau distinguish typical and atypical Alzheimer disease

(2018) Henrietta Wellington et al.   Annals of Clinical and Translational Neurology

Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays

(2018) Piotr Lewczuk et al.   JOURNAL OF ALZHEIMERS DISEASE

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase

(2018) Bruno Becker et al.   Molecular Neurodegeneration

The Cerebrospinal Fluid Aβ1–42/Aβ1–40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer’s Disease in a Clinical Setting

(2017) Ellis Niemantsverdriet et al.   JOURNAL OF ALZHEIMERS DISEASE

Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers

(2017) Kaitlin B. Casaletto et al.   NEUROLOGY

APOE ε4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease

(2016) Xiaoyan Sun et al.   Alzheimers & Dementia

Comparative analysis of cerebrospinal fluid biomarkers in the differential diagnosis of neurodegenerative dementia

(2016) Franc Llorens et al.   Alzheimers & Dementia

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease

(2016) Niklas Mattsson et al.   EMBO Molecular Medicine

Neurogranin restores amyloid β-mediated synaptic transmission and long-term potentiation deficits

(2016) Kanwardeep Singh Kaleka et al.   EXPERIMENTAL NEUROLOGY

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein

(2016) Lou Grangeon et al.   JOURNAL OF ALZHEIMERS DISEASE

A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in Belgium

(2016) Charisse Somers et al.   JOURNAL OF ALZHEIMERS DISEASE

Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer’s disease and in mild cognitive impairment due to AD

(2016) Cristina Sanfilippo et al.   JOURNAL OF NEURAL TRANSMISSION

Tau physiology and pathomechanisms in frontotemporal lobar degeneration

(2016) Liviu-Gabriel Bodea et al.   JOURNAL OF NEUROCHEMISTRY

Increased CSF neurogranin concentration is specific to Alzheimer disease

(2016) Henrietta Wellington et al.   NEUROLOGY

Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease

(2016) Rawan Tarawneh et al.   JAMA Neurology

Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's disease

(2015) Hlin Kvartsberg et al.   Alzheimers & Dementia

A monoclonal antibody-based elisa for neurogranin

(2015) Ann De Vos et al.   Alzheimers & Dementia

CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study

(2015) Michael Ewers et al.   Alzheimers & Dementia

C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease

(2015) Ann De Vos et al.   Alzheimers & Dementia

Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer’s disease

(2015) Erik Portelius et al.   BRAIN

The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer’s disease

(2015) Yannick Vermeiren et al.   Alzheimers Research & Therapy

Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease

(2015) Konstantin Hellwig et al.   Alzheimers Research & Therapy

Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease

(2015) Maartje I. Kester et al.   JAMA Neurology

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Interaction of Endogenous Tau Protein with Synaptic Proteins Is Regulated byN-Methyl-d-aspartate Receptor-dependent Tau Phosphorylation

(2012) Siddhartha Mondragón-Rodríguez et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A harmonized classification system for FTLD-TDP pathology

(2011) Ian R. A. Mackenzie et al.   ACTA NEUROPATHOLOGICA

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

(2011) Thomas J. Montine et al.   ACTA NEUROPATHOLOGICA

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion

(2011) Ryuichiro Atarashi et al.   NATURE MEDICINE

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease

(2010) Annika Thorsell et al.   BRAIN RESEARCH

Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update

(2009) Ian R. A. Mackenzie et al.   ACTA NEUROPATHOLOGICA

Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease

(2009) I. Zerr et al.   BRAIN